Thrombite™ Clot Retriever Device

OVERVIEW
Thrombite™ Stent Retrieval Device
HELICAL OPEN-SIDE STRUCTURE
HIGHER ACUTE RECANALIZATION RATE
The Thrombite™ Mechanical Retriever Device, featuring S-shaped helical open-side structure, is designed for more efficient clot removal and optimum revascularization in a wide range of vessels.

PRODUCT FEATURES
HELICAL OPEN-SIDE STRUCTURE

enables Thrombite™ retriever to efficiently entwine and clamp the clot

assures clot retention for confident removal and revascularization

OVERLAPPED STENT AT THE HELICAL OPEN-SIDE STRUCTURE

increases contact surface with thrombus and maximizes clot integration

EXCELLENT FLEXIBILITY AND VESSEL WALL APPOSITION

optimizes clot retention during smooth navigation through the tortuous anatomies

PRODUCT FEATURES
Radiopaque markers on the distal end of the device increase device visibility
3 markers for the sizes with 3.0 and 4.0mm diameter

4 markers for the sizes with 5.0 and 6.0mm diameter

Advanced stent surface treatment process

RADIAL FORCE
High radial force is designed for clot integration at the initial stage of stent expansion

Low radial force at nominal stent diameter ensures atraumatic retrieval

RADIAL FORCE
How a Stent Retriever Procedure Is Performed
Stent retriever procedure is generally performed in patients with the indications of acute cerebral infarction within six hours. After femoral artery puncture, the catheter is inserted after sheath puncture, and DSA is performed along the catheter to the brain to find the position of blocked vascular. Make the stent retriever reached the position and passing through the clot. Then release to capture the clot. After that, the stent retriever will be extracted along with the clot and finally leave your body.

ORDERING INFORMATION OF CLOT RETRIEVAL DEVICE

STENT RETRIEVAL DEVICE STRUCTURE

Thrombite™ Product code Diameter D(mm) Recommended Vessel Diameter(mm)
Min.        Max. Recommende Microcatheter ID (inch) Working Length A(mm) Stent Length B(mm) System Length(mm)

3MM CRD-3-15 3 1.5 3.0 0.21 15 27 1900
CRD-3-20 3 1.5 3.0 0.21 20 32 1900
CRD-3-25 3 1.5 3.0 0.21 25 37 1900
CRD-3-30 3 1.5 3.0 0.21 30 42 1900
4MM CRD-4-15 4 2.0 4.0 0.21 15 27 1900
CRD-4-20 4 2.0 4.0 0.21 20 32 1900
CRD-4-25 4 2.0 4.0 0.21 25 37 1900
CRD-4-30 4 2.0 4.0 0.21 30 42 1900
5MM CRD-5-15 5 2.5 5.0 0.027 15 27 1900
CRD-5-20 5 2.5 5.0 0.027 20 32 1900
CRD-5-25 5 2.5 5.0 0.027 25 37 1900
CRD-5-30 5 2.5 5.0 0.027 30 42 1900
6MM CRD-6-15 6 3.0 5.5 0.027 15 27 1900
CRD-6-20 6 3.0 5.5 0.027 20 32 1900
CRD-6-25 6 3.0 5.5 0.027 25 37 1900
CRD-6-30 6 3.0 5.5 0.027 30 42 1900

INDICATIONS
Thrombite™ Clot Retriever Device
The Thrombite™ endovascular clot retrieval devices is intended to restore blood flow by removing thrombus from a large intracranial vessel in patients experiencing ischemic stroke symptom onset.

Recently, the Billboard of the "Top 50 Most Valuable Investment Companies in China" in 2019 have been unveiled. As the first domestic company with an investment dimension, Venture50 has accompanied China's equity investment market for fourteen years. It is the authoritative reference standard for judging the investment of high-growth companies in the industry, and it is a weathervane that reflects the annual growth potential of the company. Relying on the technological innovation strength and prospects of peripheral intervention and neuro-intervention, Zylox-TonBridge Medical has stood out from more than 7,000 companies, and together with the "Internet celebrities" such as Quick, Zhihu, Himalayan, and Hi Tea, ranked among the "China's most "Top 50 Investment Companies".